Healthcare Costs Set to Rise 9% in 2027 as AI Coding Tools Add Pressure

Bypaulgruensfelder
HEALTHCARE DIVE June 11, 2026
Read Full Article →
AI-Generated Summary

Commercial healthcare costs are projected to rise 9% in 2027, the highest medical cost trend in nearly two decades, as health plans cite AI-powered documentation and coding tools as a leading inflator, according to a PwC survey of 27 health plan actuaries. Nearly 70% of respondents ranked AI documentation and coding products among the top three cost drivers for next year, with about 20% naming AI the single biggest inflator. PwC’s Glenn Hunzinger explains that AI lets providers capture more complete, reimbursable documentation, recording diagnoses and complexity that may have previously gone uncoded, without a proportional increase in actual care intensity. Provider contracting leverage from consolidation and No Surprises Act arbitration outcomes are also cited as contributing trends.

Why It Matters

For multi-site operators, AI-assisted coding isn’t just a billing efficiency play. Payers are now treating it as a cost driver to negotiate against, so groups adopting these tools should expect more documentation scrutiny and contract pushback during renewal cycles, not just faster claims.

AI documentation tools medical cost trend 2027 RCM automation claims coding intensity healthcare cost inflation payer cost forecasting

While we aim to share useful and relevant resources, we do not guarantee the accuracy of content on this site or any external links. Views and opinions expressed in referenced content do not necessarily reflect those of Healthcare Growth Strategies.

Frequently asked questions

Why do health plans say AI documentation tools are raising healthcare costs in 2027?

PwC’s survey of 27 health plan actuaries found nearly 70% rank AI-powered documentation and coding tools among the top three drivers of 2027’s projected 9% cost trend. The tools let providers capture more complete, reimbursable documentation, more diagnoses and complexity coded per visit, without a matching rise in actual care intensity.

How big is the projected 2027 medical cost trend increase?

PwC projects a 9% group medical cost trend and 8.5% individual market trend for 2027, the highest level in nearly two decades. The increase reflects AI-driven coding intensity alongside labor and supply costs, provider consolidation leverage, and No Surprises Act arbitration outcomes.

Is AI expected to ever lower healthcare costs instead of raising them?

PwC’s Glenn Hunzinger says AI could eventually bend the cost curve by automating administrative work and reducing provider burnout, but cautioned that innovation takes time in a highly regulated industry. For now, AI’s main measurable effect is higher reimbursement through more complete documentation, not lower costs.

Similar Posts

  • CMS Proposes 2027 Physician Payment Overhaul: MIPS Sunset and ACO Expansion

    Bypaulgruensfelder

    CMS’s proposed CY 2027 Physician Fee Schedule rule would sunset traditional MIPS reporting in 2029, replace it with specialty-focused MIPS Value Pathways covering roughly 98% of specialties, and make Medicare ACOs easier to join and more rewarding. The Medicare Shared Savings Program — which paid $4.1 billion in shared savings to 75% of its 476 ACOs for 2024 while generating about $2.5 billion in net Medicare savings — would gain new-entrant financial incentives, more predictable spending benchmarks, and the option to reduce beneficiary cost-sharing starting April 2027. CMS also proposes recalibrating physician payment rates, introducing MIPS Core Measures in 2027, and closing an APM incentive loophole worth an estimated $2.38 billion over a decade.

  • Q3 2026 AI Trends: What Growth Leaders Need to Track

    Bypaulgruensfelder

    The most useful AI question for growth-stage leaders in Q3 2026 has shifted from what models can do to what results they actually deliver. Summit Partners’ AI and data science team flags five developments to track: the conversation has moved from capability to production results; the binding constraint is rarely the model itself but data, workflow, and integration; agents are evolving from assistants to actors, with trust as the real limiting factor; the underlying economics of AI are being rewritten; and leaders must separate genuine signal from noise while recognizing what work stays human. The throughline is disciplined execution—turning promising pilots into dependable, measurable production systems.

  • Why Penn Medicine Is Deploying AI Agents for Patient Intake

    Bypaulgruensfelder

    Penn Medicine is integrating K Health’s AI-powered patient intake agents into its virtual primary care service, testing whether an AI ‘team member’ in the patient-provider relationship improves outcomes. The agents collect symptoms and medical history before a visit and convert them into structured summaries that feed directly into the clinician’s existing workflow — providers start appointments already informed, and patients get routed to the right level of care. The same K Health technology already runs inside virtual care programs at Cedars-Sinai, Mayo Clinic, Mass General Brigham and Hartford HealthCare, with use cases ranging from new-patient acquisition to expanding primary care access. If the pilot succeeds, Penn plans to extend the agents into in-person primary care offices and specialty clinics.

  • Patient Portal Messages Have Surged 153% Since COVID, JAMA Study Finds

    Bypaulgruensfelder

    Patient-authored messages to providers have surged 153% since the COVID-19 pandemic, and a new JAMA study using Epic data finds the increase did not reduce telehealth or in-person visits. The authors conclude that patient messaging functions as an expansion of between-visit care rather than a substitute for it, and that the steady, gradual rise makes the trend likely to persist. Messaging was most common among female patients, patients aged 40 to 64, and those in affluent neighborhoods. The operational cost is significant: the AMA reports inbox overload is now a leading driver of physician burnout, with some physicians spending up to two hours nightly clearing their in-basket, and burnout conservatively costing health systems over $5 billion a year.

  • Health System Leaders on Costs, Innovation, and the Affordability Challenge

    Bypaulgruensfelder

    Top U.S. health system executives say affordability and cost pressure now sit at the center of nearly every strategic decision. In a Chief Healthcare Executive roundtable, leaders including Hackensack Meridian Health CEO Robert Garrett argued that systems must shift from treating illness toward preventing chronic disease and keeping communities healthy. Panelists framed innovation, particularly AI, as a double-edged force: either an ingredient in solving the affordability challenge or a threat to traditional business models. The group sees significant potential for new technology to transform operations and care delivery, while cautioning that disruption is inevitable and that executives must actively manage change rather than react to it.

  • Lilly and Novo Lead Pharma AI Citation Share: What the 5W Study Found

    Bypaulgruensfelder

    Eli Lilly and Novo Nordisk are the most cited pharmaceutical companies across AI platforms, holding 12.5% and 11.5% of AI citation share respectively, according to a study by PR firm 5W covered by MM+M. Researchers ran common patient queries through ChatGPT, Claude, Gemini, Perplexity and Google AI Overviews, measuring which companies were named, cited and linked — and how extractable their source material was. Pfizer (8.5%), Johnson & Johnson (7%) and Merck (6%) round out the top five, with GLP-1 demand driving the leaders’ visibility. With roughly one-third of U.S. adults now using AI chatbots for health information, citation share is emerging as a measurable brand-visibility metric for healthcare marketers.